The effects of ovariectomy and estrogen treatment on the dopamine inhibition of gonadotropin and prolactin release
- PMID: 572372
- DOI: 10.1210/jcem-49-2-182
The effects of ovariectomy and estrogen treatment on the dopamine inhibition of gonadotropin and prolactin release
Abstract
The suppressive action of dopamine (DA) on circulating gonadotropin and PRL levels is found to be positively correlated with their basal serum concentrations. Thus, DA inhibition is greater in ovariectomized (agonadal) women than in normal women on day 2 of their menstrual cycles, and the reverse is observed for PRL. Pretreatment of agonadal subjects with estrogen lowers the basal levels of LH and FSH and thereby proportionately decreases the suppressive effects of DA. Estrogen treatment elevates the basal level of PRL in agonadal subjects and also the PRL-inhibiting effect of DA. These findings indicate that castration and estrogen treatment significantly influence the inhibitory effect of DA on gonadotropin and PRL release.
Similar articles
-
Inhibition of gonadotropin and prolactin release by dopamine: effect of endogenous estradiol levels.J Clin Endocrinol Metab. 1978 Sep;47(3):494-8. doi: 10.1210/jcem-47-3-494. J Clin Endocrinol Metab. 1978. PMID: 122409
-
Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome.J Clin Invest. 1976 May;57(5):1320-9. doi: 10.1172/JCI108400. J Clin Invest. 1976. PMID: 770505 Free PMC article.
-
Catecholamines and pituitary function. I. Effects of catecholamine synthesis inhibition and subsequent catecholamine infusion on gonadotropin and prolactin serum levels in normal cycling women and in women with hyperprolactinemic amenorrhea.Horm Res. 1984;19(3):158-70. doi: 10.1159/000179883. Horm Res. 1984. PMID: 6425187
-
Feedback effects of estradiol and progesterone upon gonadotropin and prolactin release.Obstet Gynecol. 1981 Jul;58(1):10-6. Obstet Gynecol. 1981. PMID: 6787487
-
Increased luteinizing hormone sensitivity to dopamine inhibition in polycystic ovary syndrome.J Clin Endocrinol Metab. 1981 Feb;52(2):231-4. doi: 10.1210/jcem-52-2-231. J Clin Endocrinol Metab. 1981. PMID: 7462389
Cited by
-
Unveiling the Neurotransmitter Symphony: Dynamic Shifts in Neurotransmitter Levels during Menstruation.Reprod Sci. 2025 Jan;32(1):26-40. doi: 10.1007/s43032-024-01740-3. Epub 2024 Nov 19. Reprod Sci. 2025. PMID: 39562466 Review.
-
Dopamine decreases release of luteinizing hormone releasing hormone from superfused rat mediobasal hypothalamus.J Endocrinol Invest. 1985 Aug;8(4):373-6. doi: 10.1007/BF03348517. J Endocrinol Invest. 1985. PMID: 3905934
-
Control of prolactin secretion.Klin Wochenschr. 1990 Dec 4;68(23):1157-67. doi: 10.1007/BF01815271. Klin Wochenschr. 1990. PMID: 2126309 Review.
-
Amplification of LH response to LHRH by dopamine infusion in eugonadal women.J Endocrinol Invest. 1981 Jan-Mar;4(1):55-8. doi: 10.1007/BF03349415. J Endocrinol Invest. 1981. PMID: 6787110
-
Acute effects of L-dopa and bromocriptine on serum PRL, LH and FSH levels in patients with hyperprolactinemic and normoprolactinemic polycystic ovary syndrome.J Endocrinol Invest. 1987 Aug;10(4):389-95. doi: 10.1007/BF03348155. J Endocrinol Invest. 1987. PMID: 3119696
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources